An FDA advisory panel of medical experts has recommended against proposed wider use of Zimmer’s Dynesys spine stabilization device, according to a report by Reuters.
Zimmer is asking for stand-alone use of Dynesys, a series of screws and flexible spacers that aim to help align and support the spine, which is already approved for use in patients with back problems who undergo surgical fusion.
Panel members questioned how the device would hold up over time and expressed concern about possible breakage, but they added that the device holds promise.
Read Reuters’ report on Zimmer’s Dynesys spinal device.
Captiva Spine doubled its revenue year-over-year in the first quarter of 2025, largely due to accelerated market adoption of its…
Ten thousand patients have been treated with Augmedics’ Xvision augmented reality spine system, the company said April 22. The milestone…
The highest-paid CFO of orthopedic medtech companies in the U.S. saw more than $12 million per year in total compensation…
Comments are closed.